Who owns Silomat?
Silomat is owned by STADA (Germany), which has owned the brand since 2021.[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: STADA's strong growth journey continues in 2025, STADA Arzneimittel AG, 18 March 2026. Last checked .
Key facts
- Current owner
- STADA Arzneimittel AG reported
- Owned since
- Owner HQ
- 🇩🇪 Germany, Bad Vilbel
- Origin
- 🇩🇪 Germany
- Category
- Consumer health › Over-the-counter medicine › Cold
- Last verified
- · 3 sources
About Silomat
Silomat is a German range of remedies for dry, irritating coughs, sold as pentoxyverine juice and drops for adults and children from two years old, dextromethorphan capsules and lozenges, and a marshmallow and honey syrup. STADA agreed on 28 June 2021 to buy it from Sanofi with 15 other consumer health brands across 13 countries, including Mitosyl, Frubiase and Modafen, and later described the purchase as made in mid-2021. STADA sells Silomat in Germany.
Ownership timeline of Silomat
Where Silomat sits in STADA
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full STADA ownership tree →
See the full STADA brand portfolio (6) →
Other brands owned by STADA
STADA controls 6 brands on Brandtree, 3 of them in consumer health.
Also in consumer health
Other brands in cold, and who owns them
The 36 brands in cold on Brandtree belong to 21 owners. The largest is Krka, with 5; STADA has 3.
| Brand | Owner | Owner based in |
|---|---|---|
| Herbion | Krka | 🇸🇮 Slovenia |
| Breathe Right | Prestige Consumer Healthcare | 🇺🇸 United States |
| Lemsip | Reckitt | 🇬🇧 United Kingdom |
| Dimestil | Birzeit Pharmaceutical | 🇵🇸 Palestine |
| HealthCareAisle | Dr. Reddy's | 🇮🇳 India |
| Tukol | Genomma Lab | 🇲🇽 Mexico |
| Benadryl | Kenvue | 🇺🇸 United States |
| Allergosan | Sopharma | 🇧🇬 Bulgaria |
About the owner: STADA
STADA is a privately held company headquartered in Bad Vilbel, Germany, founded in 1895. Brandtree records 6 brands under its control.
STADA Arzneimittel AG is a German maker of consumer health products, generic medicines and specialty pharmaceuticals, based in Bad Vilbel, Hesse, that sells in more than 100 countries. It traces its roots to a pharmacists' association formed in Dresden in 1895 to make shared preparations, and it stayed a cooperative until it became a corporation in 1970. Bain Capital and Cinven took it over in 2017, and a squeeze-out in November 2020 left all its shares with the holding company Nidda Healthcare. CapVest completed the purchase of their majority stake on 31 March 2026, with both firms keeping minority stakes. STADA's group sales in 2025 were €4,296 million, with 11,749 employees.
🇩🇪 Silomat and other German brands
Brandtree records a controlling owner for 265 brands that began in Germany. 96 of them (36%) are now controlled by a company headquartered in another country; Silomat is not one of them.
- Aspirin — Bayer 🇩🇪
- Atrauman — HARTMANN 🇩🇪
- Hansaplast — Beiersdorf 🇩🇪
- 3 Glocken — Princes Group 🇬🇧
- A. Lange & Söhne — Richemont 🇨🇭
- ABOUT YOU — Zalando 🇩🇪
Frequently asked questions
Who is the parent company of Silomat?
The parent company of Silomat is STADA, a privately held company headquartered in Germany.
Is Silomat German?
Yes. Silomat originated in Germany and its owner, STADA, is also headquartered in Germany.
Since when has STADA owned Silomat?
STADA has owned Silomat since 2021.
Is Silomat still owned by STADA?
Yes. As of 24 October 2026, Silomat is still owned by STADA. The ownership record was last checked against primary sources on that date.
Sources (3) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] STADA's strong growth journey continues in 2025 — STADA Arzneimittel AG, Official press release, published 18 March 2026; retrieved 24 October 2026.
- [2] STADA — Silomat — STADA Arzneimittel AG, Official document; retrieved 24 October 2026.
- [3] STADA further grows European consumer healthcare portfolio by acquiring 16 well-established brands from Sanofi — STADA Arzneimittel AG, Official press release, published 28 June 2021; retrieved 24 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.